CHR Citadelle
Liège 4000
1 studies enrolling now · 13 studies all time
What they study most
Anti-myostatin, Atrophy, Back Pain, Crohn's Disease, Cystic Fibrosis, Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy (DMD), Failed Back Surgery Syndrome, Mantle Cell Lymphoma, Muscular Atrophy, Muscular Atrophy, Spinal, Myelodysplastic Syndrome
Studies at this site
- A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy — Recruiting now
- A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy — Completed
- Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping — Running, not enrolling
- Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab — Running, not enrolling
- Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection — Stopped early
- Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
- Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
- Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) — Completed
- Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) — Stopped early
- Lead Registry for Optim Leads — Completed
- A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects — Completed
- Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
- Spinal Cord Stimulation for Predominant Low Back Pain — Completed